Unravelling the Mystery Between Structure and Sustained Clinical Outcomes
Targeted biologics have revolutionised the treatment and outlook of patients with inflammatory joint diseases. The combination of high-cost long-term therapy straining healthcare systems with impending expiry of key biologics patents has led to heightened interest in the development of biosimilars....
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
European Medical Journal
2016-07-01
|
Series: | European Medical Journal Rheumatology |
Subjects: | |
Online Access: | http://emjreviews.com/wp-content/uploads/Unravelling-the-Mystery-Between-Structure-and-Sustained-Clinical-Outcomes.pdf |